Electrogenetherapy of established B16 murine melanoma by using an expression plasmid for HIV-1 viral protein R
Novel therapies and delivery methods directed against malignancies such as melanoma, and particularly metastatic melanoma, are needed. The HIV-1 accessory protein Vpr (viral protein R) has previously been demonstrated to induce G2 cell cycle arrest as well as in vitro growth inhibition/killing of nu...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
Scholar Commons
2006
|
| Subjects: | |
| Online Access: | http://scholarcommons.usf.edu/etd/2621 http://scholarcommons.usf.edu/cgi/viewcontent.cgi?article=3620&context=etd |